Integral BioSystems Enhances IP Asset Valuation with Broad Patent Allowance of its NanoM™ Sustained Release Platform
The USPTO has issued a broad allowance on a patent application for Integral BioSystems’ NanoM, the firm’s sustained release platform formulation technology. BEDFORD, MA, US, December 5, 2017 /EINPresswire.com/ -- Boston-area drug development firm Integral …